4-bromo-2-fluoro-1-methoxybenzene

We are 4-bromo-2-fluoro-1-methoxybenzene CAS:2357-52-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 4-bromo-2-fluoro-1-methoxybenzene
CAS.NO: 2357-52-0
Synonyms: 3-fluoro-4-methoxybromobenzene;
Benzene,4-bromo-2-fluoro-1-methoxy;
4-Bromo-2-fluoroanisole;
3,4-Difluorobenzoic acid;
2-fluoro-4-bromo anisole;
Molecular Formula:C7H6BrFO
Molecular Weight: 205.02400
 
Physical and Chemical Properties:
Density: 1.59 g/mL at 25 °C(lit.)
Melting point: 16 °C
Boiling point: 84 °C7 mm Hg(lit.)
Flash point:  209 °F
Index of Refraction:1.545
 
Specification:
Appearance: colorless liquid
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:   Applications for organic intermediates

4-bromo-2-fluoro-1-methoxybenzene


Related News: The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.5-bromo-7,7-dimetilbenzo [c] fluoreno CAS:954137-48-5 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.2,4-DIHYDRO-4 – [(4- (4-HYDROXYPHENYL) -1-PIPERAZINYL) PHENYL] -2- (1-METHYLPROPYL) -3H-1,2,4-TRIAZOLE-3-ONE CAS:106461-41-0 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.53250-83-2 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.

Related Products
Product Name
chenodeoxycholic acid View Details
4,5-Difluoro-2-Iodobenzoic Acid View Details
3-Phenoxy-1-propanol View Details
6-bromo-2-chloro-3-fluoropyridine manufacturer 2-(Heptafluoropropoxy)hexafluoropropyl Trifluorovinyl Ether manufacturer 4-ethenyl-2,3-dihydro-1-benzofuran manufacturer 3-Amino-4-methoxybenzamide manufacturer 2-(1H-1,2,4-Triazol-1-yl)-2′,4′-difluoroacetophenone manufacturer